Wolverine Trading’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-8,682
| Closed | -$4.04M | – | 6194 |
|
|
2025
Q2 | $3.54M | Buy |
8,682
+4,086
| +89% | +$1.71M | ﹤0.01% | 1281 |
|
|
2025
Q1 | $2.3M | Sell |
4,596
-5,320
| -54% | -$2.88M | ﹤0.01% | 1507 |
|
|
2024
Q4 | $5.14M | Buy |
9,916
+8,986
| +966% | +$4.94M | ﹤0.01% | 1188 |
|
|
2024
Q3 | $571K | Buy |
+930
| New | +$551K | ﹤0.01% | 2934 |
|
|
2024
Q1 | – | Sell |
-129,188
| Closed | -$72.5M | – | 5303 |
|
|
2023
Q4 | $68.6M | Buy |
129,188
+126,973
| +5,732% | +$61.5M | 0.07% | 143 |
|
|
2023
Q3 | $1.12M | Buy |
2,215
+1,506
| +212% | +$803K | ﹤0.01% | 2040 |
|
|
2023
Q2 | $365K | Sell |
709
-1,381
| -66% | -$745K | ﹤0.01% | 2899 |
|
|
2023
Q1 | $1.18M | Sell |
2,090
-107,602
| -98% | -$60.6M | ﹤0.01% | 1762 |
|
|
2022
Q4 | $60.4M | Buy |
109,692
+106,868
| +3,784% | +$56.6M | 0.09% | 165 |
|
|
2022
Q3 | $1.46M | Sell |
2,824
-11,896
| -81% | -$6.66M | ﹤0.01% | 1662 |
|
|
2022
Q2 | $7.89M | Sell |
14,720
-1,281
| -8% | -$705K | 0.01% | 611 |
|
|
2022
Q1 | $9.52M | Buy |
16,001
+9,844
| +160% | +$5.65M | 0.01% | 718 |
|
|
2021
Q4 | $4.1M | Sell |
6,157
-6,807
| -53% | -$4.25M | ﹤0.01% | 1282 |
|
|
2021
Q3 | $7.51M | Sell |
12,964
-26,952
| -68% | -$14.8M | 0.01% | 1004 |
|
|
2021
Q2 | $20.3M | Buy |
39,916
+475
| +1% | +$224K | 0.03% | 423 |
|
|
2021
Q1 | $17.8M | Sell |
39,441
-12,574
| -24% | -$6M | 0.03% | 437 |
|
|
2020
Q4 | $24M | Buy |
52,015
+25,481
| +96% | +$11.9M | 0.04% | 348 |
|
|
2020
Q3 | $11.5M | Sell |
26,534
-4,243
| -14% | -$1.75M | 0.03% | 478 |
|
|
2020
Q2 | $10.8M | Buy |
30,777
+333
| +1% | +$112K | 0.03% | 434 |
|
|
2020
Q1 | $8.68M | Buy |
30,444
+1,521
| +5% | +$480K | 0.03% | 490 |
|
|
2019
Q4 | $9.4M | Buy |
28,923
+14,566
| +101% | +$4.42M | 0.02% | 704 |
|
|
2019
Q3 | $4.13M | Buy |
14,357
+12,183
| +560% | +$3.49M | 0.01% | 976 |
|
|
2019
Q2 | $638K | Buy |
2,174
+360
| +20% | +$99.2K | ﹤0.01% | 2468 |
|
|
2019
Q1 | $497K | Sell |
1,814
-9,063
| -83% | -$2.26M | ﹤0.01% | 2785 |
|
|
2018
Q4 | $2.42M | Sell |
10,877
-542
| -5% | -$127K | 0.01% | 1272 |
|
|
2018
Q3 | $2.79M | Buy |
11,419
+8,547
| +298% | +$1.97M | 0.01% | 1393 |
|
|
2018
Q2 | $593K | Hold |
2,872
| – | – | ﹤0.01% | 2859 |
|
|
2018
Q1 | $593K | Sell |
2,872
-26,820
| -90% | -$5.63M | ﹤0.01% | 2859 |
|
|
2017
Q4 | $5.64M | Buy |
29,692
+25,300
| +576% | +$4.85M | 0.02% | 786 |
|
|
2017
Q3 | $831K | Buy |
+4,392
| New | +$795K | ﹤0.01% | 2077 |
|
Other funds holding TMO
Wolverine Trading's TMO Position: Q3 2025 in Review
Wolverine Trading sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 8,682 shares — an estimated $4.04M sold.
Wolverine Trading first reported a position in TMO in Q3 2017 and held it in 30 quarters. The position peaked at $68.6M in Q4 2023. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Wolverine Trading reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
- Wolverine Trading sold 8,682 Thermo Fisher Scientific shares in Q3 2025, an estimated $4.04M.
- Wolverine Trading first reported a position in Thermo Fisher Scientific in Q3 2017 and held it in 30 quarters.
- Wolverine Trading's Thermo Fisher Scientific position peaked at $68.6M in Q4 2023.
- 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.